Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) (C-Term) Peptide
RIPK1
Reactivity: Human
BP
Sodium azide
-
- Target See all RIPK1 products
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
- Protein Region
- C-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
14 amino acids near the carboxy terminus of human RIP1.
Human
-
-
- Application Notes
- RIP1 peptide is used for blocking the activity of RIP1 antibody. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37 °C.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
- Synonyms
- RIP Peptide, RIP1 Peptide, D330015H01Rik Peptide, Rinp Peptide, Rip1 Peptide, rip1 Peptide, ripk1 Peptide, xRIP1beta Peptide, xrip1 Peptide, receptor interacting serine/threonine kinase 1 Peptide, receptor (TNFRSF)-interacting serine-threonine kinase 1 Peptide, receptor interacting serine/threonine kinase 1 L homeolog Peptide, RIPK1 Peptide, Ripk1 Peptide, ripk1.L Peptide
-
You are here:
